1Me Namarn Omorain C. Helicobacter pylori and gastric cancer, Ital J Gastrocnteml Hepatol, 1998, 30(Suppl 3) : 5294 - 5298.
2张亚历主编.胃肠疾病的内镜.病理与超声内镜诊断.北京:军事医学科学出版社,2000.73-80.
3Ming Si Chun, Epithelial polyps of the stomach. In Pathology of the gastrointestinal tract, 2nd edition, edited by Si-Chun Ming and Harvey Goldman, published by Williams & Wilkins, 1998, 1.
4Papa A, Cammarota G, Tu A, et al. Histologic types and smvaillance of gastric polyps: a seven year clinico-pathological study. Hepato- gastroenterol, 1998, 45:579 - 582.
5Hongo M,Fujimoto K.Incidence and risk factor of fundic gland polyp and hyperplastic polyp in longterm proton pump inhibitor therapy:a prospective study in Japan[J].J Gastroenterol,2010,45:618 ～ 624.
6Camack SW,G enta RM,Graham DY,et al.Management of gastric polyps:a pathology-based guide for gastroenterologists[J].Nat RevGastroenterol Hepatol,2009,6(6):331 ～341.
7Abraham SC,Singh VK,Yardly JH,et al.Hyperplasic polyps of the stomach:associatons with histologic patterrns of gsatritis and gastric atrophy[J].Am J Surg Pathol,2001,25(4):500 ～507.
8Murakami K,Mitomi H,Yamashita K,et al.p53,but not c-Ki-ras,mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transfornation in gastric hyperplastic polyps[J].Am J Clin Pathol,2001,115(2):224 ～234.
9Yao T,Kajiwara M,Kuroiwa S,et al.Malignant transformation of gastric hyperplastic polyps:alteration of phenotypes,proliferative activity,and p53 expression[J].Hum Pathol,2002,33(10):1016～1022.
10Han AR,Sung CO,Kim KM,et al.The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations:a suggestion of indication for endoscopic polypectomy[J].Gut Liver,2009,3(4):271 ～275.
